Filing metadata

Accession number
0001493152-21-024641
Form type
Form 4
Filer
SAB Biotherapeutics, Inc.
CIK
CIK 1833214
Filed
Oct 05, 2021
Reporting period
Oct 01, 2021
Description
Insider transaction

Explore SEC Filings Hub